| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/05/2006 | EP0871673B1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
| 04/05/2006 | EP0862453B1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 04/05/2006 | EP0741792B1 Herpesvirus pre-(viral dna replication) enveloped particles |
| 04/05/2006 | EP0740705B1 Thermostable variants of neutral proteases of bacillus stearothermophilus |
| 04/05/2006 | EP0710288B1 Adenoviral vectors for treatment of hemophilia |
| 04/05/2006 | EP0649435B1 Membrane-associated immunogens of mycobacteria |
| 04/05/2006 | CN1756844A Optimizing glycan processing in plants |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756835A Translocating enzyme as a selection marker |
| 04/05/2006 | CN1756764A Novel proteins and use thereof |
| 04/05/2006 | CN1756562A Influenza virus vaccine |
| 04/05/2006 | CN1249229C Soluble T cell receptor |
| 04/05/2006 | CN1249222C Process for raising yield of glutamine transaminase prepared by fermination process by adding hydroxylamine |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249079C Process for partitioning of proteins |
| 04/04/2006 | US7022821 Tumor Antigen Derived Gene-15 (TADG-15); a detectably labeled antibody specific for the TADG-15 protein which has a molecular size of 100 kDa and comprises CUB, LDLR and serine protease domains; useful in the diagnosis or treatment of breast and ovarian cancer in particular |
| 04/04/2006 | US7022526 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 04/04/2006 | US7022501 Binding DNA in the presence of homologous recombination proteins, then transfecting into cells by electroporation for replication; genetic engineering; gene cloning kit |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022499 Nucleic acids encoding differentiation inhibitor delta 2 |
| 04/04/2006 | US7022498 Designated "PRO444"; fusion proteins, vectors, host cells |
| 04/04/2006 | US7022496 Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA |
| 04/04/2006 | US7022490 Myc-binding zinc finger proteins, their preparation and their use |
| 04/04/2006 | US7022489 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease |
| 04/04/2006 | US7022488 Functional coupling of T1Rs and T2Rs by Gi proteins, and cells-based assays for the identification of T1R and T2R modulators |
| 04/04/2006 | US7022323 Prevent infections using envelope glycoprotein; binding to antibody |
| 04/04/2006 | CA2316755C Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/04/2006 | CA1341503C Molecular cloning and expression of human il-3 |
| 03/30/2006 | WO2006034395A2 Methods and compositions relating to mannuronic acid specific binding peptides |
| 03/30/2006 | WO2006034332A2 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/30/2006 | WO2006033481A1 Soluble toll-like receptor 4 protein |
| 03/30/2006 | WO2006033413A1 Method of quantifying peptide |
| 03/30/2006 | WO2006033386A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 03/30/2006 | WO2006033368A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 03/30/2006 | WO2006001832A3 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells |
| 03/30/2006 | WO2005106009A3 Lactoferrin cleavage of neisserial proteins |
| 03/30/2006 | WO2005099745A3 Gcp-170 fusion proteins and uses thereof |
| 03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
| 03/30/2006 | WO2004096978A3 Production of high mannose proteins in plant culture |
| 03/30/2006 | WO2004063714A3 Methods for the detection, analysis and isolation of nascent proteins |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060070134 Diagnosis and treatment of fanconi's anemia |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069240 Deposited in flat, structural platelets in reflective tissues of the squid Euprymna scolopes; protein-based reflectors in squids provide a striking example of nanofabrication in animal systems; modifying a refractive index of a reflectin |
| 03/30/2006 | US20060069239 Epididymis-specific gene as potential contraceptive target |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068483 Extracellular serine protease |
| 03/30/2006 | US20060068482 cleaves myeloid/lymphoid or mixed-lineage leukemia protein, which is required for proper HOX gene regulation; Taspase1 inhibitors; leukemia |
| 03/30/2006 | US20060068481 Human kinases |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | US20060068479 Porcine forssman synthetase protein, cDNA, genomic organization, and regulatory region |
| 03/30/2006 | US20060068478 Site specific incorporation of keto amino acids into proteins |
| 03/30/2006 | US20060068474 endothelial-monocyte activating polypeptide III (EMAP III) cDNA encoding such proteins; anticarcinogenic agent; diagnostically or therapeutically useful |
| 03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
| 03/30/2006 | US20060068470 Antifreeze proteins from basidiomy cetes |
| 03/30/2006 | US20060068469 Bacterial vector systems |
| 03/30/2006 | US20060068468 for modulating growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron; comprising an altered Growth differentiation factor 11 (GDF11)-binding domain of an ActRII receptor |
| 03/30/2006 | US20060068467 Rhodococcus polynucleotide cluster that contains 4 nucleotide sequences that encode 2 polypeptides having nitrile hydratase activity, an auxiliary protein P15K that activates this enzyme, and a cobalt transporter |
| 03/30/2006 | US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia |
| 03/30/2006 | US20060068465 useful researching on neuroplasticity and pathology of neurodegenerative disorders |
| 03/30/2006 | US20060068464 Regulation of human g protein coupled receptor |
| 03/30/2006 | US20060068463 Natural killer cell activating factor ii |
| 03/30/2006 | US20060068462 Method |
| 03/30/2006 | US20060068461 Transglycosylation method and protein having transglycosylation activity |
| 03/30/2006 | US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068451 Dimeric fluorescent polypeptides |
| 03/30/2006 | US20060068449 N-terminal and C-terminal markers in nascent proteins |
| 03/30/2006 | US20060068448 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; immunosuppressants; insoluble cytoplasmic membrane proteins, free of cell wall |
| 03/30/2006 | US20060068445 Novel soluble CD14 antigen |
| 03/30/2006 | US20060068441 Alternative pol kappa nucleotide and amino acid sequence and methods for using |
| 03/30/2006 | US20060068439 Ucp4 |
| 03/30/2006 | US20060068438 Identification of gene expression alterations underlying the aging process in mammals |
| 03/30/2006 | US20060068437 Meg-3 protein |
| 03/30/2006 | US20060068425 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068390 Dna amplification and sequencing in collapsible emulsions |
| 03/30/2006 | US20060068386 Complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 03/30/2006 | US20060068382 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/30/2006 | US20060068060 Carboxypeptidase of cocoa |
| 03/30/2006 | US20060067940 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
| 03/30/2006 | US20060067936 IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
| 03/30/2006 | US20060067934 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 03/30/2006 | US20060067933 Soluble receptor BR43x2 and methods of using |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067926 Novel serine threonine kinase member, h2520-59 |
| 03/30/2006 | CA2619256A1 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 03/30/2006 | CA2580981A1 Stabilized human igg4 antibodies |
| 03/30/2006 | CA2580840A1 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/30/2006 | CA2580620A1 Method of detecting hepatitis b virus s antigen |
| 03/30/2006 | CA2562208A1 Pcka modifications and enhanced protein expression in bacillus |
| 03/29/2006 | EP1640447A1 BIOACTIVE PEPTIDE-PRODUCING STRAINS OF i ENTEROCOCCUS FAECALIS /i , BIOACTIVE PEPTIDES AND APPLICATIONS THEREOF |
| 03/29/2006 | EP1639115A1 Protein production system |
| 03/29/2006 | EP1639111A2 Protein expression system |
| 03/29/2006 | EP1639095A2 Method to increase protein production in culture |
| 03/29/2006 | EP1639085A2 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 03/29/2006 | EP1639084A2 Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase |